A Phase 3, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Efficacy and Safety of Deucravacitinib in Adults with Active Sjögren’s Syndrome (POETYK SjS-1)

Authors
Category Primary study
Registry of TrialsClinical Trials Peruvian Registry
Year 2024
This article has no abstract
Epistemonikos ID: ede8dfbc3766c35202e2944b506def1f9a6e4628
First added on: Apr 11, 2025